Original Articles
 

By Dr. Tony Phan , Mrs. Verity Phan , Dr. Kevin Murray
Corresponding Author Dr. Tony Phan
University of Western Australia, School of Dentistry, Oral Biology Research Labs, - Australia
Submitting Author Dr. Tony Phan
Other Authors Mrs. Verity Phan
School of Dentistry, Oral Biology Research Labs, University of Western Australia, - Australia

Dr. Kevin Murray
School of Mathematics and Statistics, Faculty of Engineering, Computing and Mathematics, Universit, - Australia

OBSTETRICS AND GYNAECOLOGY

ABO Blood Group, Nausea and Vomiting in Pregnancy, Human Chorionic Gonadotrophin, Hyperemesis Gravidarum

Phan T, Phan V, Murray K. Blood Group A Is Associated With Higher Incidence Of Nausea And Vomiting In Pregnancy. WebmedCentral OBSTETRICS AND GYNAECOLOGY 2010;1(9):WMC00526
doi: 10.9754/journal.wmc.2010.00526
No
Submitted on: 06 Sep 2010 06:03:47 AM GMT
Published on: 06 Sep 2010 08:43:50 AM GMT

Abstract


Background: To examine the association between the risk of nausea and vomiting of pregnancy (NVP) with the ABO blood groups.

Method: One hundred and eighteen women who were currently or previously pregnant volunteered for a study on NVP. All women completed a questionnaire assessing the severity of NVP and their general condition. Their obstetrical and physical characteristics as well as their blood type were also recorded. Participants were allocated to one of two groups: NVP- (no vomiting and nausea) and NVP+ (minimum of 1 vomiting episodes a day with nausea).  Patients were also grouped according to their ABO blood type.

Results: Logistic regression analysis of the data indicates that those with Blood Group A have a higher risk of NVP compared to other Blood Groups (Odd Ratio of 3.43; p-value < 0.05).

Conclusions: Our preliminary data indicated that patients with Blood Group A are at a higher risk to have episodes of NVP compared to other Blood Groups. We hypothesize that the association between NVP and Blood Group A is due to the similarity between the A antigen and human chorionic gonadotrophin. A larger study as well as molecular-based approaches will be needed in order to unequivocally confirm this.

Introduction


Nausea and vomiting of pregnancy, colloquially known as morning sickness, is a multi-factorial condition that can contribute to adverse effects on the mother and foetus [1]. NVP affects around 50% to 70% of all pregnant women, and causes 28% to alter their usual lifestyle activities [2-4]. Furthermore, hyperemesis gravidarum, a severe form of NVP has been described as largely incapacitating to the point that little concern is left for the foetus [2]. As a result, morning sickness remains a significant public health issue that has an impact on the quality of life and health of the mother, foetus and their families. 

Despite the significance of NVP and the plethora of studies examining this condition, the etiology of NVP is still unclear [5]. Past research has focused on several social and hormonal factors. Social variables include stress, body mass index, age and education [6-9]. Hormonal variables include estrogen, progesterone and especially human chorionic gonadotrophin (hCG) [5, 10, 11].

Notwithstanding the extensive studies in NVP, no team has examined the association between NVP and the ABO blood group. Research on the ABO blood groups have demonstrated associations with a variety of conditions such as deep vein thrombosis [12], cancer [13-15], organ transplantation [16], malaria [17] and even suicide [18]. Interestingly, both NVP and maternal blood conditions are typically associated with pregnancy complications [19, 20], thus it is likely that each of these influences the other. Therefore, it is possible that a link between NVP and the ABO blood group exists. Accordingly, this pilot study aims to examine this theory.

Methods


This pilot study began after obtaining approval from the Human Ethics Committee at the University of Western Australia. A cross-sectional research design with convenience sampling was used to recruit 118 women who were currently or previously pregnant and over 18 years of age. All women completed a questionnaire assessing their general condition, severity of NVP as well as their blood type and physical characteristics. Participants were categorised to one of two groups: NVP- (no vomiting and nausea) and NVP+ (minimum of 1 vomiting episodes a day with nausea).  Patients were also grouped according to their ABO blood group: A, B, O and AB.

Statistical analysis was performed using Logistic Regression.  The response was NVP (positive or negative) and the possible predictors used were ABO blood group, age, and number of previous pregnancies.  Due to the nature of the data exact inference was carried out.  All analysis was carried out using SAS software Version 9.1.3, Cary NC, USA.

Results


Out of the 118 women who enrolled in the study, 43 were in the NVP- group while 75 were in the NVP+ group. In addition, 45 participants were in Blood Group O, 55 were in A, 10 were in B and 8 were in AB. Logistic regression analysis indicated that women with Blood Group A have a higher risk of having NVP compared to blood group O (OR: 3.69 95% CI 1.45-9.83, p-value < 0.05; Illustration 1). The data for AB, B and O indicate no statistically significant differences; however the small sample sizes particularly in groups B and AB groups would contribute to this.

When comparing blood group A to a combination of the other blood groups we observe OR=3.43 (95% CI 1.45, 8.56), P<0.05.  No statistically significant effects of age or previous pregnancies were observed.

Discussion


In this pilot study we have demonstrated that women with Blood Group A are at risk of NVP compared to other Blood Groups. This is a novel concept since no other study has specifically examined the link between ABO blood groups and NVP. This association can be explained by the biological similarities of the A antigen and hCG. Human chorionic gonadotrophin belongs to the cysteine knot growth factor family [21] and is a heterodimer consisting of an α and β subunit. Marz and colleagues (1973) observed that highly purified hCG significantly cross-reacted with blood group A [22]. More specifically, nearly all of the cross-reactivity resided within the α-subunit with β producing negligible activity [22]. In addition, the α -subunit contained enough structural similarities to the A-antigen to impart the conformation necessary for the reactivity with blood group A [22]. Interestingly, luteinizing hormone, which has a similar α -subunit to hCG, did not exhibit any cross-reactivity [22] indicating a specific association between hCG and the A blood group. It is not known how the structural and serological similarities between hCG and the A-antigen can cause NVP. However, it is interesting to note that hCG can increase the synthesis of estrogen and progesterone [23], two other hormones that are also implicated in NVP [24]. In addition, one can not deny the existence of studies showing different levels of hCG associated with NVP [24, 25]. In fact high levels of hCG are further linked with hyperemesis gravidarum, a severe form of NVP [24, 25]. Thus, there is a possibility that this tentative link may exist. Moreover, it is also possible that NVP is an immune response as has been suggested by previous studies [26, 27].

It must be noted that the ABO blood groups have been implicated in a wide variety of conditions, disorders and diseases since its discovery in 1901 [28, 29]. This includes transplantation, malaria and even suicide [16-18]. A recent study observed that different blood groups are associated with different types and severity of cancers [28]. For instance, women with blood type A were more likely to develop an intestinal tumour [28]. Thus the ABO blood group remains an important factor when assessing different conditions and diseases.

The results shown in this study, that blood group A is associated with NVP, are pre-liminary. The connection between hCG, ABO blood and NVP is still at an infancy and a larger population size is required for each ABO blood group in order to unequivocally determine this association. In addition, molecular and cellular-based approaches will need to be completed in order to determine the exact mechanism of action. Taken altogether, the results in this study as well as the literature do warrant further investigation. Discovering what factors are associated with NVP will increase our understanding of its etiology as well as increasing our knowledge of pregnancy and related health care.

Reference(s)


1. Lane, C.A. (2007) Nausea and vomiting of pregnancy: a tailored approach to treatment. Clin Obstet Gynecol 50, 100-111.
2. Nelson-Piercy, C. (1997) Hyperemesis gravidarum Current Obstetrics and Gynaecology 7, 98-103.
3. Nelson-Piercy, C., Fayers, P., and de Swiet, M. (2001) Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. Bjog 108, 9-15.
4. O'Brien, B., and Naber, S. (1992) Nausea and vomiting during pregnancy: effects on the quality of women's lives. Birth 19, 138-143.
5. Goodwin, T.M. (2002) Nausea and vomiting of pregnancy: an obstetric syndrome. Am J Obstet Gynecol 186, S184-189.
6. Ben-Aroya, Z., Lurie, S., Segal, D., Hallak, M., and Glezerman, M. (2005) Association of nausea and vomiting in pregnancy with lower body mass index. Eur J Obstet Gynecol Reprod Biol 118, 196-198.
7. Kuo, S.H., Wang, R.H., Tseng, H.C., Jian, S.Y., and Chou, F.H. (2007) A comparison of different severities of nausea and vomiting during pregnancy relative to stress, social support, and maternal adaptation. J Midwifery Womens Health 52, e1-7.
8. Lacroix, R., Eason, E., and Melzack, R. (2000) Nausea and vomiting during pregnancy: A prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol 182, 931-937.
9. Neri, A., Levavi, H., and Ovadia, J. (1995) Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects. Br J Obstet Gynaecol 102, 671.
10.Carlsen, S.M., Vanky, E., and Jacobsen, G. (2003) Nausea and vomiting associate with increasing maternal androgen levels in otherwise uncomplicated pregnancies. Acta Obstet Gynecol Scand 82, 225-228.
11. Davis, D.C. (1996) The discomforts of pregnancy. J Obstet Gynecol Neonatal Nurs 25, 73-81.
12. Ohira, T., Cushman, M., Tsai, M.Y., Zhang, Y., Heckbert, S.R., Zakai, N.A., Rosamond, W.D., and Folsom, A.R. (2007) ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 5, 1455-1461.
13. Adamian, R.T. (2005) [Blood-type and rhesus distribution in Armenian women with endometrial carcinoma]. Vopr Onkol 51, 575-576.
14. Suadicani, P., Hein, H.O., and Gyntelberg, F. (2007) ABO phenotypes and inflammation-related predictors of lung cancer mortality: the Copenhagen Male Study - a 16-year follow-up. Eur Respir J 30, 13-20.
15. Tursen, U., Tiftik, E.N., Unal, S., Gunduz, O., Kaya, T.I., Camdeviren, H., and Ikizoglu, G. (2005) Relationship between ABO blood groups and skin cancers. Dermatol Online J 11, 44.
16. Bryan, C.F., Nelson, P.W., Shield, C.F., Warady, B.A., Winklhofer, F.T., Murillo, D., and Wakefield, M.R. (2007) Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. Am J Transplant 7, 1181-1184.
17. Rowe, J.A., Handel, I.G., Thera, M.A., Deans, A.M., Lyke, K.E., Kone, A., Diallo, D.A., Raza, A., Kai, O., Marsh, K., Plowe, C.V., Doumbo, O.K., and Moulds, J.M. (2007) Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A 104, 17471-17476.
18. Lester, D. (2005) Predicting suicide in nations. Arch Suicide Res 9, 219-223.
19. Chin, R.K. (1989) Antenatal complications and perinatal outcome in patients with nausea and vomiting-complicated pregnancy. Eur J Obstet Gynecol Reprod Biol 33, 215-219.
20. Naeye, R.L. (1981) Maternal blood pressure and fetal growth. Am J Obstet Gynecol 141, 780-787.
21. Lapthorn, A.J., Harris, D.C., Littlejohn, A., Lustbader, J.W., Canfield, R.E., Machin, K.J., Morgan, F.J., and Isaacs, N.W. (1994) Crystal structure of human chorionic gonadotropin. Nature 369, 455-461.
22. Marz, L., Bahl, O.P., and Mohn, J.F. (1973) Blood-group activity of human chorionic gonadotropin. Biochem Biophys Res Commun 55, 717-723.
23. Lei, Z.M., and Rao, C.V. (2001) Neural actions of luteinizing hormone and human chorionic gonadotropin. Semin Reprod Med 19, 103-109.
24. Verberg, M.F., Gillott, D.J., Al-Fardan, N., and Grudzinskas, J.G. (2005) Hyperemesis gravidarum, a literature review. Hum Reprod Update 11, 527-539.
25. Rao, C.V., and Lei, Z.M. (2007) The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol 269, 2-8.
26. Ismail, S.K., and Kenny, L. (2007) Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol 21, 755-769.
27. Leylek, O.A., Cetin, A., Toyaksi, M., and Erselcan, T. (1996) Hyperthyroidism in hyperemesis gravidarum. Int J Gynaecol Obstet 55, 33-37.
28. Jesch, U., Endler, P.C., Wulkersdorfer, B., and Spranger, H. (2007) ABO blood group. Related investigations and their association with defined pathologies. ScientificWorldJournal 7, 1151-1154.
29. Wu, O., Bayoumi, N., Vickers, M.A., and Clark, P. (2007) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis.

Source(s) of Funding


None

Competing Interests


None

Disclaimer


This article has been downloaded from WebmedCentral. With our unique author driven post publication peer review, contents posted on this web portal do not undergo any prepublication peer or editorial review. It is completely the responsibility of the authors to ensure not only scientific and ethical standards of the manuscript but also its grammatical accuracy. Authors must ensure that they obtain all the necessary permissions before submitting any information that requires obtaining a consent or approval from a third party. Authors should also ensure not to submit any information which they do not have the copyright of or of which they have transferred the copyrights to a third party.
Contents on WebmedCentral are purely for biomedical researchers and scientists. They are not meant to cater to the needs of an individual patient. The web portal or any content(s) therein is neither designed to support, nor replace, the relationship that exists between a patient/site visitor and his/her physician. Your use of the WebmedCentral site and its contents is entirely at your own risk. We do not take any responsibility for any harm that you may suffer or inflict on a third person by following the contents of this website.

Reviews
1 review posted so far

Comments
0 comments posted so far

Please use this functionality to flag objectionable, inappropriate, inaccurate, and offensive content to WebmedCentral Team and the authors.

 

Author Comments
0 comments posted so far

 

What is article Popularity?

Article popularity is calculated by considering the scores: age of the article
Popularity = (P - 1) / (T + 2)^1.5
Where
P : points is the sum of individual scores, which includes article Views, Downloads, Reviews, Comments and their weightage

Scores   Weightage
Views Points X 1
Download Points X 2
Comment Points X 5
Review Points X 10
Points= sum(Views Points + Download Points + Comment Points + Review Points)
T : time since submission in hours.
P is subtracted by 1 to negate submitter's vote.
Age factor is (time since submission in hours plus two) to the power of 1.5.factor.

How Article Quality Works?

For each article Authors/Readers, Reviewers and WMC Editors can review/rate the articles. These ratings are used to determine Feedback Scores.

In most cases, article receive ratings in the range of 0 to 10. We calculate average of all the ratings and consider it as article quality.

Quality=Average(Authors/Readers Ratings + Reviewers Ratings + WMC Editor Ratings)